Want to join the conversation?
The biotechnology company $CELG reported a 3Q15 loss due to higher costs on Juno Therapeutics collaboration and expenses on purchase of Receptos. Net loss was $34.1MM or $0.04 per share compared to a profit of $508.5MM or $0.61 per share last year. Revenue grew to $2.33Bil from $1.98Bil. Adjusted EPS rose to $1.23 from $0.97.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.